Skip to main content
. Author manuscript; available in PMC: 2021 Mar 24.
Published in final edited form as: Cancer Prev Res (Phila). 2019 May 28;12(8):557–566. doi: 10.1158/1940-6207.CAPR-19-0053

Table 1A.

Study entry criteria

Inclusion:
 • Age over 21.
 • Smoking history > 30 pack years.
Exclusion:
 • Inability to provide informed consent (e.g. cognitive impairment, severe psychiatric disorders).
 • Hypersensitivity to grapes and related products.
 • Liver dysfunction (abnormal liver function tests).
 • Renal dysfunction (abnormal serum creatinine).
 • End stage respiratory disease (FEV1<0.8 liters, resting or exertional hypoxemia, to select patients with adequate reserve to undergo bronchoscopy and complete the study).
 • Unstable angina.
 • Malignancy within 5 years, excluding non-melanoma type skin cancer or stage I NSCLC post curative resection without evidence of recurrence.
 • Pregnancy.
 • Systemic corticoid steroid therapy.
 • Coagulopathy.
 • Concurrent use of grapes or grape related products.
 • Unwilling to refrain from drinking more than 1 glass of wine a day.
 • Patients with concurrent medical conditions that may interfere with completion of tests, therapy, or the follow up schedule.